Status:
UNKNOWN
Novel Therapy for Poor Responders Management
Lead Sponsor:
Al Baraka Fertility Hospital
Conditions:
Poor Ovarian Response
Eligibility:
FEMALE
22-45 years
Phase:
NA
Brief Summary
Unfortunately for some infertile women, gonadotrophin administration results in a desultory ovarian response. While this is commonly due to diminished ovarian reserve, as indicated by advanced age and...
Detailed Description
Unfortunately for some infertile women, gonadotrophin administration results in a desultory ovarian response. While this is commonly due to diminished ovarian reserve, as indicated by advanced age and...
Eligibility Criteria
Inclusion
- All with AFC ≤3,
- AMH;≤0.5
- and they give only ≤3 oocytes in their previous cycles
Exclusion
- \-
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04310293
Start Date
March 10 2020
End Date
August 1 2020
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-BARAKA FERTILITY HOSPITAL
Manama, Bahrain, 15006